Endobronchial valve improves symptoms, QoL in patients with emphysema
14 Oct 2019
byAudrey Abella
Use of the Zephyr endobronchial valve (EBV) led to significant improvements in a range of patient-reported outcomes (PROs) including multiple domains of respiratory symptoms and quality of life (QoL) in patients with severe emphysema, according to the post hoc results of the LIBERATE* trial presented at ERS 2019.
Endobronchial valve improves symptoms, QoL in patients with emphysema
14 Oct 2019